Key Performance Indicators - Comparative Analysis for Major Brands of Pharmaceutical Production Industry in Romania

Due to the growing importance of emerging markets in Romania, the supply chains of pharmaceutical companies are forced to reevaluate strategies and improve their production and distribution processes. For this reason, it is of utmost importance for the companies that produce pharmaceutical products to define and measure the progress towards their objectives. This study desires to investigate what are the most important financial factors that play role in Romania’s major pharmaceutical brands’ evolution in the past 4 years. For this purpose, quantitative statistical analysis and comparative analysis were used. In order to make the analysis of the selected companies and to establish the most important financial factors we used Key Performance Indicators (KPI) as a research tool that enabled us to determine which factors were playing the major role in their evolution.

Along with the important financial factors that affected the evolution of the companies in the last 4 years the study will also determine if by correlating the net income, the leverage and the asset turnover and by using profitability ratios we can determine the relevance of a company’s price per share towards its investors.